Pharmaceutical lobbying in Brazil: a missing topic in the public health research agenda
ABSTRACT In the US, where registration of lobbyists is mandatory, the pharmaceutical industry and private health-care providers spend huge amounts of money seeking to influence health policies and government decisions. In Brazil, where lobbying lacks transparency, there is virtually no data on drug...
Saved in:
Main Author: | Francisco José Roma Paumgartten (Author) |
---|---|
Format: | Book |
Published: |
Universidade de São Paulo.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lobbying by Big Pharma, bottlenecks for clinical research, and loosening of ethical standards in Brazil
by: Francisco José Roma Paumgartten
Published: (2016) -
In the Onyx Lobby
by: Wells, Carolyn, 1862-1942 -
Citizen Lobby From Capacity to Influence
by: Thomas Olsen, Leif
Published: (2015) -
Citizen Lobby From Capacity to Influence
by: Thomas Olsen, Leif
Published: (2015) -
Lobbying the Autocrat The Dynamics of Policy Advocacy in Nondemocracies
Published: (2023)